2016 –

Morphology and Visual Acuity in Aflibercept and Ranibizumab Therapy for Neovascular Age-Related Macular Degeneration in the VIEW Trials.
Waldstein SM, Simader C, Staurenghi G, Chog NV, Mitchell P, Jaffe GJ, Lu C, Katz TA, Schmidt-Erfurth U.
Publication: Ophthalmology 2016

Correlation of 3-Dimensionally Quantified Intraretinal and Subretinal Fluid With Visual Acuity in Neovascular Age-Related Macular Degeneration.
Waldstein SM, Philip AM, Leitner R, Simader C, Langs G, Gerendas BS, Schmidt-Erfurth U.
Publication: JAMA Ophthalmol. 2016

Choroidal Line Scan Measurements in Swept-Source Optical Coherence Tomography as Surrogates for Volumetric Thickness Assessment.
Gerendas BS, Hecht A, Kundi M, Waldstein SM, Deak G, Simader C, Montuoro A, Schmidt-Erfurth U, M. Funk
Publication: Am J Ophthalmol. 2016

Predictive Value of Retinal Morphologic Features for Visual Acuity Outcomes of Different Ranibizumab Treatment Regimens for Neovascular Age-Related Macular Degeneration.
Waldstein SM, Wright J, Warburton J, Margaron P, Simader C, Schmidt-Erfurth U.
Publication:Ophthalmology. 2016